US FDA issues import alert for Mohali-made Ranbaxy drugs
Washington : The US Food and Drug Administration Monday issued an import alert against drug products manufactured at Indian drug
Read More
ranbaxy
Ranbaxy to pay $420,000 in US for selling sub-standard drugs
Washington : Indian generic drug manufacturer Ranbaxy will pay Idaho state in northwestern US nearly $420,000 to settle civil and
Read MoreRanbaxy to pay $500 mn to settle US fraud charges
A subsidiary of Indian generic drug-maker Ranbaxy Laboratories has pleaded guilty to federal charges of selling adulterated drugs with intent
Read More